Probing the origins, diagnosis and treatment of amyloid diseases using antibodies
- 31 October 2004
- Vol. 86 (9-10) , 589-600
- https://doi.org/10.1016/j.biochi.2004.09.012
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Solid State NMR Reveals a pH-dependent Antiparallel β-Sheet Registry in Fibrils Formed by a β-Amyloid PeptideJournal of Molecular Biology, 2004
- Mapping Aβ Amyloid Fibril Secondary Structure Using Scanning Proline MutagenesisJournal of Molecular Biology, 2004
- Protein folding and misfoldingNature, 2003
- Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolutionJournal of Molecular Medicine, 2003
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Immunomodulation of the Human Prion Peptide 106–126 AggregationBiochemical and Biophysical Research Communications, 2001
- Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the β-domainJournal of Molecular Biology, 2000
- Antibody binding defines a structure for an epitope that participates in the PrP C → PrP Sc conformational change 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1999
- Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packingThe EMBO Journal, 1999
- A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform 1 1Edited by M. YanivJournal of Molecular Biology, 1997